| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |